Randall E. Meyer, a cardiologist from Jefferson City, Mo., pleaded guilty to making false statements to receive higher reimbursement on healthcare claims.

More than 60 percent of patients said they rarely or never discussed their adherence to medications with their cardiologists, according to a survey-based study conducted at four cardiology practices in and around Chicago.

Novartis announced a program that includes more than 40 clinical trials that will examine the safety, efficacy and real world outcomes of patients with heart failure who receive sacubitril/valsartan (Entresto).

Patients with type 2 diabetes who received semaglutide had statistically significant reductions in cardiovascular risk compared with patients who received placebo, according to a phase 3a trial.

Theranos told officials at the Centers for Medicare & Medicaid Services that the company voided reports in 2014 and 2015 from its Edison blood testing devices, the Wall Street Journal reports. 

Researchers from Iceland discovered a variant of a gene that was associated with reduced levels of non-high density lipoprotein (HDL) cholesterol and a reduction in the risk of coronary artery disease.

Harry Persaud, MD, a cardiologist from Ohio, was ordered to pay nearly $5.5 million in restitution for performing unnecessary heart procedures, Cleveland.com reports. 

From May 17 to May 24, the World Hypertension League (WHL) is sponsoring a “Know Your Numbers” campaign to raise awareness of high blood pressure. The goal is to have three million people receive blood pressure screenings.